Clinical Trials

  • Principal Investigator:

    Michael T Yin, MD
    The study is exploring the impact of gender, age, HIV infection, and menopausal status on dental health. The study is open to men and women, ages 35-70.
  • Principal Investigator:

    Michael T Yin, MD
    The study is exploring the impact of gender, age, HIV infection, and menopausal status on dental health. The study is open to men and women, ages 35-70.
  • Principal Investigator:

    Magdalena E Sobieszczyk, MD
    We are looking for individuals over 18 years old who are interested in learning more about COVID-19 prevention research studies. We will ask you to complete a brief questionnaire to find out if you may be eligible for one of our studies. We can then schedule a phone call, teleconference, or in-person education visit so you can learn about the research we do and decide if you want to participate in one of our studies. Your responses to this questionnaire will be kept strictly confidential.
  • Principal Investigator:

    Michael T Yin, MD
    This study is looking at hepatitis B virus (HBV) vaccination in adults 18 to 70 years of age living with HIV around the world. Hepatitis B is a serious viral infection that affects the liver and is transmitted through blood and body fluids. A vaccine (a shot of medicine given through a needle) can prevent HBV, but there is no cure. A new vaccine approved by the United States Food and Drug Administration (FDA), called HEPLISAV-B, has been shown to provide a better response in other people who have not responded well to the older HBV vaccines. The purpose of this study is to find out whether...
  • Principal Investigator:

    Deborah A. Theodore, MD
    This is a study for people with symptoms of long COVID. We are looking for people over the age of 18 who are interested in participating in a study to understand whether a mindfulness meditation intervention can help improve symptoms of long COVID. Study participation lasts 12 weeks and is fully remote.
  • Principal Investigator:

    Anne-Catrin Uhlemann, MD
    We want to examine if wastewater based surveillance of SARS-CoV-2 is a valuable tool to detect SARS-CoV-2 positive individuals on campus prior to being identified by routine individual testing. We aim to enroll CU employees and students for active surveillance of SARS-CoV-2 carriage to be able to validate waste water surveillance findings. If successful this approach might inform targeted testing and can improve safety on campus.
  • Principal Investigator:

    Jason E Zucker, MD
    The purpose of this study is to evaluate how well tecovirimat works for the treatment of human monkeypox virus infection and if the study drug is safe in people. Tecovirimat is approved by the Food and Drug Administration (FDA) to treat smallpox in adults and children, but its use in this study is considered investigational. Tecovirimat has been given safely to some people with monkeypox in the recent outbreak and is currently being studied in several ongoing studies outside of the US, but none of the studies have shown whether or not this study drug works to treat monkeypox. 530 people will...
  • Principal Investigator:

    Delivette Castor, PhD
    We want to learn more about how COVID-19 virus is spread in the community and in the households. To answer this question, we are looking for people who test positive for COVID to measure how many of their close contacts also test positive, and how long the virus persists in the household. We will also study risk factors for getting COVID-19.

Pages